Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel J Yates

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Blood Advances|February 5, 2025
What to do with the weight while preparing for CAR-T?Samuel J Yates, Ishan Roy
Blood Advances|June 25, 2025
Moving beyond the eyeball test for fitness assessment in AMLSamuel J Yates, Heidi D Klepin
JCO Oncology Practice|April 5, 2022
Updates in the Management of Relapsed and Refractory Acute Lymphoblastic Leukemia: An Urgent Plea for New Treatments Is Being Answered!Adam S DuVall, Jori Sheade, Daniela Anderson, et al.
Cancers|February 13, 2026
Sarcopenia in Older Adults with Hematologic Malignancies: A Comprehensive Review of Epidemiology, Prognosis, and InterventionsSamuel J Yates, Nadine H Abdallah, Konstantinos Christofyllakis, et al.
Cancer Medicine|February 13, 2020
The prognostic value of standardized phase angle in adults with acute leukemia: A prospective studySamuel J Yates, Susan Lyerly, Megan Manuel, et al.
Blood Advances|May 29, 2024
Optimization of older adults by a geriatric assessment-guided multidisciplinary clinic before CAR T-cell therapySamuel J Yates, John F Cursio, Andrew Artz, et al.
Medical Science Educator|August 30, 2021
Feasibility and Impact of a Student-Led, Semi-Structured, Near-Peer Student Guides Program on Navigating Through Medical SchoolColleen E Laurence, Jessie R Jones, Shane N Stone, et al.
Haematologica|July 24, 2025
Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Samuel J Yates, Julian J Weiss, Abigail Sneider, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Blood Advances|February 5, 2025
What to do with the weight while preparing for CAR-T?Samuel J Yates, Ishan Roy
Blood Advances|June 25, 2025
Moving beyond the eyeball test for fitness assessment in AMLSamuel J Yates, Heidi D Klepin
JCO Oncology Practice|April 5, 2022
Updates in the Management of Relapsed and Refractory Acute Lymphoblastic Leukemia: An Urgent Plea for New Treatments Is Being Answered!Adam S DuVall, Jori Sheade, Daniela Anderson, et al.
Cancers|February 13, 2026
Sarcopenia in Older Adults with Hematologic Malignancies: A Comprehensive Review of Epidemiology, Prognosis, and InterventionsSamuel J Yates, Nadine H Abdallah, Konstantinos Christofyllakis, et al.
Cancer Medicine|February 13, 2020
The prognostic value of standardized phase angle in adults with acute leukemia: A prospective studySamuel J Yates, Susan Lyerly, Megan Manuel, et al.
Blood Advances|May 29, 2024
Optimization of older adults by a geriatric assessment-guided multidisciplinary clinic before CAR T-cell therapySamuel J Yates, John F Cursio, Andrew Artz, et al.
Medical Science Educator|August 30, 2021
Feasibility and Impact of a Student-Led, Semi-Structured, Near-Peer Student Guides Program on Navigating Through Medical SchoolColleen E Laurence, Jessie R Jones, Shane N Stone, et al.
Haematologica|July 24, 2025
Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Samuel J Yates, Julian J Weiss, Abigail Sneider, et al.
Pageof 1